Primary Axillary Hyperhidrosis Clinical Trial
Twenty patients with PAH had 1 session of Fractionated microneedle radiofrequency treatment. Clinical improvement was evaluated using a Hyperhidrosis Disease Severity Scale (HDSS) and photographs were taken using the starch-iodine test at every visit and 4 weeks, 8 weeks, and 24 weeks after the treatment. Skin biopsies were obtained from 3 of the enrolled patients before and after treatment. The satisfaction and adverse reactions of the research participants were recorded at every follow-up visit.
Hyperhidrosis Disease Severity Scale (HDSS)Score = 1 My sweating is never noticeable and never interferes with my daily activitiesScore = 2 My sweating is tolerable but sometimes interferes with my daily activitiesScore = 3 My sweating is barely tolerable and frequently interferes with my daily activitiesScore = 4 My sweating is intolerable and always interferes with my daily activities ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03627468 -
A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis
|
Phase 3 | |
| Completed |
NCT03658616 -
Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.
|
Phase 3 | |
| Completed |
NCT02286765 -
Ulthera® System for Treating Axillary Hyperhidrosis
|
N/A | |
| Completed |
NCT04599907 -
Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
|
N/A | |
| Completed |
NCT03037788 -
Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis
|
Phase 1 | |
| Terminated |
NCT01722461 -
A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis
|
N/A | |
| Completed |
NCT05863104 -
Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis
|
Phase 2 | |
| Not yet recruiting |
NCT04159610 -
Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis
|
Phase 2 | |
| Completed |
NCT01799824 -
Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis
|
Phase 2 | |
| Completed |
NCT03785587 -
A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis
|
Phase 2 | |
| Completed |
NCT03054480 -
Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis
|
N/A |